May 5, 2026 07:04AM Climb Bio reports positive subcutaneous budoprutug data in healthy volunteers

May 5, 2026 03:08AM Chardan Starts Climb Bio (CLYM) at Buy

Apr 21, 2026 05:55AM Climb Bio (CLYM) PT Raised to $18 at Oppenheimer

Apr 15, 2026 04:13AM Mizuho Starts Climb Bio (CLYM) at Outperform

Apr 7, 2026 05:54PM BTIG on Climb Bio (CLYM): FDA fast track for Budoprutug in pMN 'validating event'

Mar 24, 2026 03:58AM B.Riley Starts Climb Bio (CLYM) at Buy

Mar 17, 2026 04:28PM Truist Securities Starts Climb Bio (CLYM) at Buy

Mar 10, 2026 04:06PM Raymond James Starts Climb Bio (CLYM) at Strong Buy

Mar 5, 2026 05:30PM Climb Bio, Inc. (CLYM) Misses Q4 EPS by 7c

Mar 5, 2026 06:54AM Wedbush Starts Climb Bio (CLYM) at Outperform

Feb 13, 2026 03:47AM Piper Sandler Starts Climb Bio (CLYM) at Overweight

Jan 8, 2026 07:05AM Climb Bio begins dosing patients in membranous nephropathy trial

Dec 31, 2025 04:15PM Climb Bio files lawsuit against Alumis over drug asset dispute

Dec 30, 2025 03:02PM Freedom Capital Markets Starts Climb Bio (CLYM) at Buy

Dec 18, 2025 06:47AM Climb Bio (CLYM) PT Raised to $11 at H.C. Wainwright

Oct 21, 2025 07:00AM Climb Bio names Adam Villa, Ashley Jones to senior VP roles

Oct 16, 2025 06:02AM William Blair Starts Climb Bio (CLYM) at Outperform

Oct 13, 2025 06:37AM H.C. Wainwright Starts Climb Bio (CLYM) at Buy

Sep 30, 2025 07:16AM Oppenheimer on Climb Bio (CLYM): 'Positive CLYM116 Reveal Carves Path Forward in IgAN'

Sep 30, 2025 06:06AM Climb Bio (CLYM) PT Raised to $8 at BTIG

Sep 29, 2025 07:01AM Climb Bio reports preclinical data for IgAN drug candidate

Aug 15, 2025 08:59AM Baird Initiated Climb Bio (CLYM) at Outperform

Aug 12, 2025 04:24PM Climb Bio, Inc. (CLYM) Tops Q2 EPS by 5c

Jun 18, 2025 07:01AM Climb Bio (CLYM) Appoints Edgar D. Charles as Chief Medical Officer

Jun 6, 2025 06:47AM Oppenheimer Starts Climb Bio (CLYM) at Outperform,. PT $10

May 22, 2025 06:20AM BTIG Starts Climb Bio (CLYM) at Buy

May 14, 2025 05:16PM Climb Bio, Inc. (CLYM) Misses Q1 EPS by 16c

Apr 1, 2025 07:03AM Climb Bio (CLYM) Appoints Kim Cobleigh Drapkin and Bo Cumbo to its Board

Mar 25, 2025 04:41PM Climb Bio, Inc. (CLYM) Reports Q4 Loss of $0.13

Feb 24, 2025 07:04AM Climb Bio (CLYM) Appoints Perrin Wilson as Chief Business Officer

Dec 19, 2024 07:03AM Climb Bio (CLYM) to be Added to the Nasdaq Biotechnology Index

Dec 2, 2024 06:20AM Leerink Partners Starts Climb Bio (CLYM) at Outperform

Nov 15, 2024 12:59AM Climb Bio, Inc. (CLYM) Reports Q3 Loss of $0.13

Oct 11, 2024 12:32PM Climb Bio (CLYM) Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024

Oct 2, 2024 09:01AM Eliem Therapeutics (ELYM) Rebrands as Climb Bio (CLYM)